# Axillary Reverse Mapping in Breast Cancer

> **NCT05040685** · NA · COMPLETED · sponsor: **Hospital Universitari de Bellvitge** · enrollment: 43 (actual)

## Conditions studied

- Lymph Node Cancer Metastatic

## Interventions

- **PROCEDURE:** Axillary mapping reverse

## Key facts

- **NCT ID:** NCT05040685
- **Lead sponsor:** Hospital Universitari de Bellvitge
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2023-07-01
- **Final completion:** 2023-07-01
- **Target enrollment:** 43 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05040685

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05040685, "Axillary Reverse Mapping in Breast Cancer". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05040685. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*